References
- Hamblin T. Autoimmune disease and its management in chronic lymphocytic leukemia. Chronic lymphocytic leukemias. 2nd ed, B Cheson. Marcel Dekker, New York 2001; 435–458
- Mauro F, Foa R, Cerretti R, Giannarelli D, Coluzzi S, Mandelli F, Girelli G. Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features. Blood 2000; 95: 2786–2792
- Kyasa M J, Parrish R S, Schichman S A, Zent C S. Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma. Am J Hematol 2003; 74: 1–8
- Hall A M, Vickers M A, McLeod E, Barker R N. Rh autoantigen presentation to helper T cells in chronic lymphocytic leukemia by malignant B cells. Blood 2005; 105: 2007–2015
- Scrivener S, Kaminski E, Demaine A, Prentice A. Analysis of the expression of critical activation/interaction markers on peripheral blood T cells in B-cell chronic lymphocytic leukaemia: evidence of immune dysregulation. Br J Haematol 2001; 112: 959–964
- Myint H, Copplestone J, Orchard J, Craig V, Curtis D, Prentice A, et al. Fludarabine-related autoimmune hemolytic anaemia in patients with chronic lymphocytic leukaemia. Br J Haematol 1995; 91: 341–344
- Jønsson V, Bock J E, Hilden J, Houlston R S, Wiik A. The influence of pregnancy on development of autoimmunity in chronic lymphocytic leukemia. Leuk Lymphoma 2006; 47: 1481–1487
- Messmer B T, Albesiano E, Efremov D G, Ghiotto F, Allen S L, Kolitz J, et al. Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J Exp Med 2004; 200: 519–525